Search Videos and More

Showing 1 - 12 of 136 results

Previous| 1 | 2 | 3 ...12 |Next


Dana-Farber Research Publication 8.1.2022 News

Dana-Farber Research Publication 8.1.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publications News

Dana-Farber Research Publications

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023 News

U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023

For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.
New Protein Complex Structure Reveals Possible Ways To Target Key Cancer Pathway News

New Protein Complex Structure Reveals Possible Ways To Target Key Cancer Pathway

Scientists have solved the structure of an important complex of RAS-pathway proteins, explaining how known mutations lead to disease and suggesting potential new binding sites for cancer drugs.
GU Oncology Conference Highlights: ASCO 2022 Symposium

GU Oncology Conference Highlights: ASCO 2022

In the following videos, faculty from Dana-Farber Cancer Institute review GU Oncology highlights from the 2022 ASCO Annual Meeting, held in Chicago, June 3-7, 2022.
The Young-Onset Colorectal Cancer Center’s Gut Instincts Series Symposium

The Young-Onset Colorectal Cancer Center’s Gut Instincts Series

The Young-Onset Colorectal Cancer Center’s Gut Instincts Series is a quarterly webinar for healthcare professionals to learn more about colorectal cancer and the unique challenges individuals diagnosed under the age of 50 face. Events are hosted by Young-Onset Colorectal Cancer Center Director Dr. Kimmie Ng and include a panel of medical experts and a patient perspective.
Dana-Farber Researchers Launch New Project to Investigate How Neighborhoods Contribute to Prostate Cancer Inequity News

Dana-Farber Researchers Launch New Project to Investigate How Neighborhoods Contribute to Prostate Cancer Inequity

Researchers at Dana-Farber Cancer Institute and the Rutgers University Cancer Institute are investigating what it is about neighborhoods that may increase a Black man’s risk of dying from prostate cancer.
FDA Approves New Treatment Option For Glioma News

FDA Approves New Treatment Option For Glioma

The U.S. Food and Drug Administration’s accelerated approval of a two-drug therapy for solid tumors carrying a specific mutation in the BRAF gene is a prime example of this trend. For patients with glioma brain cancer that harbors the mutation, the ruling is a landmark.
Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical Care News

Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical Care

Results of a study of molecular tumor profiling in young patients revealed a high rate of genetic alterations with potential for impacting clinical care, including clarifying diagnoses and treatment with matched, precision cancer drugs.
Study Finds Breast Cancers with Low Levels of HER2 Protein Are Not a Distinct Subtype of the Disease News

Study Finds Breast Cancers with Low Levels of HER2 Protein Are Not a Distinct Subtype of the Disease

When researchers discovered that breast cancers with lower levels of HER2 often respond to a trastuzumab-and-chemotherapy drug conjugate, they wondered whether such tumors represent a distinct subtype of breast cancer, with its own unique behavior and prognosis.
ASCO 2022 Highlights Symposium

ASCO 2022 Highlights

Below please find highlights of key advances in cancer research and an overview of Dana-Farber faculty presentations at ASCO.
Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program News

Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program

U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center #1 in the nation in its 2022-23 Best Children's Hospitals report. Dana-Farber/Boston Children's has been recognized as one of the top three pediatric cancer centers in the country each year since the ranking's inception, earning more #1 rankings than any other program.

Showing 1 - 12 of 136 results

Previous| 1 | 2 | 3 ...12 |Next